4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0000950170-23-066394
Director acquired 2,857,142 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ellias Helen K. Director | 2023-11-24 | Option exercise | +2,857,142 | 2,857,142 | I: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Ellias Helen K. Director | 2023-11-24 | Option exercise · Series A-1 Convertible Preferred Stock | −1,800 | $1,000.00 | $1,800,000 | 0 | I: show line 2 in the form |
Loading xslF345X05/ownership.xml…